{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:55:11Z","timestamp":1791482111842,"version":"4.3.4"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Multiple myeloma is a hematologic cancer caused by abnormal plasma cell proliferation in the bone marrow and is associated with significant immune dysfunction. Neutrophils, essential components of the innate immune response, may function poorly in patients with multiple myeloma, increasing the risk of infection and affecting disease progression. This study aimed to systematically evaluate the extent of neutrophil dysfunction in patients with newly diagnosed and relapsed multiple myeloma. The study employed a cross-sectional analytical design and recruited 72 participants: 30 multiple myeloma patients and 42 age- and sex-matched healthy controls from the University Teaching Hospital and the Cancer Diseases Hospital of Lusaka, Zambia. 4 mL of venous blood was collected from all participants in ethylenediaminetetraacetic acid vacutainers for laboratory analysis. Neutrophils were isolated from whole blood using Polymorphprep\u2122, and functionality was assessed using in vitro assays, including a phagocytosis assay using fluorescently labeled bacterial particles and a reactive oxygen species assay using the fluorescent probe 2\u2019, 7\u2019-Dichlorodihydrofluorescein diacetate, measured by flow cytometry. Statistical analysis was performed using STATA. Neutrophils from multiple myeloma patients demonstrated significantly lower phagocytic capacity (45.0% vs 75.9%, P\u2009&lt;\u20090.001) and reactive oxygen species production (44.7% vs 74.9%, P\u2009&lt;\u20090.001) compared to controls. The logistic regression analysis demonstrated strong associations between multiple myeloma and both reactive oxygen species (OR=5097.6, P\u2009&lt;\u20090.001) and phagocytic dysfunction (OR=7272.7, P\u2009&lt;\u20090.001). By contrast, age, sex, white blood cell count, and absolute neutrophil count were not significantly associated with these outcomes. The study found that patients with multiple myeloma exhibit qualitative impairment of neutrophil function, despite normal quantitative neutrophil counts, underscoring the importance of functional immune monitoring in patient management.<\/jats:p>","DOI":"10.1371\/journal.pone.0360063","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:24:56Z","timestamp":1791480296000},"page":"e0360063","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional characterization of neutrophils in patients with multiple myeloma"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0522-3103","authenticated-orcid":true,"given":"Kapina","family":"Mwampembwa","sequence":"first","affiliation":[{"name":"School of Health Sciences, University of Zambia","place":["Lusaka, Zambia"],"department":["Department of Biomedical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mweni","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of Zambia","place":["Lusaka, Zambia"],"department":["Department of Biomedical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humphrey","family":"Mwape","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of Zambia","place":["Lusaka, Zambia"],"department":["Department of Biomedical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Daka","sequence":"additional","affiliation":[{"name":"Pathology Department, the University Teaching Hospital","place":["Lusaka, Zambia"],"department":["Haematology Section"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Nzobokela","sequence":"additional","affiliation":[{"name":"Ndola Teaching Hospital","place":["Ndola, Zambia"],"department":["Pathology Department"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-2369","authenticated-orcid":true,"given":"Chrispin","family":"Chisanga","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of Zambia","place":["Lusaka, Zambia"],"department":["Department of Biomedical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sody","family":"Munsaka","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of Zambia","place":["Lusaka, Zambia"],"department":["Department of Biomedical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"1","key":"pone.0360063.ref001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/medsci9010003","article-title":"Epidemiology, Staging, and Management of Multiple Myeloma","volume":"9","author":"SA Padala","year":"2021","journal-title":"Med Sci (Basel)"},{"issue":"1","key":"pone.0360063.ref002","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41408-024-01115-6","article-title":"A roadmap towards improving outcomes in multiple myeloma","volume":"14","author":"M Mohty","year":"2024","journal-title":"Blood Cancer J"},{"issue":"6","key":"pone.0360063.ref003","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"pone.0360063.ref004","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"pone.0360063.ref005","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-016-2135-z","article-title":"Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies","volume":"73","author":"C Guillerey","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"pone.0360063.ref006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple Myeloma: Diagnosis and Treatment","volume":"91","author":"SV Rajkumar","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"pone.0360063.ref007","doi-asserted-by":"crossref","first-page":"1609692","DOI":"10.3389\/fmed.2025.1609692","article-title":"Global, regional, and national burden of multiple myeloma, 1990 to 2021 and predictions to 2035: an analysis of the Global Burden of Disease Study 2021","volume":"12","author":"X Miao","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"pone.0360063.ref008","doi-asserted-by":"crossref","first-page":"198539","DOI":"10.1155\/2014\/198539","article-title":"Immunological dysregulation in multiple myeloma microenvironment","volume":"2014","author":"A Romano","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1","key":"pone.0360063.ref009","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41598-020-58859-x","article-title":"High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling","volume":"10","author":"A Romano","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0360063.ref010","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/cancers13061353","article-title":"Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression","volume":"13","author":"A D\u00edaz-Tejedor","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"pone.0360063.ref011","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/cancers13040625","article-title":"The Immune Microenvironment in Multiple Myeloma: Friend or Foe?","volume":"13","author":"R Lopes","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0360063.ref012","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/ijpm.ijpm_505_21","article-title":"Immunophenotypic characterization of normal and abnormal plasma cells in bone marrow of newly diagnosed multiple myeloma patients","volume":"66","author":"NP Awasthi","year":"2023","journal-title":"Indian J Pathol Microbiol"},{"issue":"5","key":"pone.0360063.ref013","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/ijms25052929","article-title":"Neutrophils at the Crossroads: Unraveling the Multifaceted Role in the Tumor Microenvironment","volume":"25","author":"D Awasthi","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"pone.0360063.ref014","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","article-title":"The Neutrophil","volume":"54","author":"GL Burn","year":"2021","journal-title":"Immunity"},{"issue":"8","key":"pone.0360063.ref015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"A Mantovani","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"pone.0360063.ref016","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nri1785","article-title":"Neutrophils and immunity: challenges and opportunities","volume":"6","author":"C Nathan","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"pone.0360063.ref017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaci.2005.05.036","article-title":"Innate immune responses to infection","volume":"116","author":"MF Tosi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0360063.ref018","first-page":"9671604","article-title":"Neutrophils and Immunity: From Bactericidal Action to Being Conquered","volume":"2017","author":"T-S Teng","year":"2017","journal-title":"J Immunol Res"},{"issue":"3","key":"pone.0360063.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004651","article-title":"Neutrophils: Between host defence, immune modulation, and tissue injury","volume":"11","author":"P Kruger","year":"2015","journal-title":"PLoS Pathog"},{"key":"pone.0360063.ref020","doi-asserted-by":"crossref","first-page":"1074779","DOI":"10.3389\/fonc.2022.1074779","article-title":"Distinct phenotype of neutrophil, monocyte, and eosinophil populations indicates altered myelopoiesis in a subset of patients with multiple myeloma","volume":"12","author":"KL Ong","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0360063.ref021","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1365-2141.1997.1873007.x","article-title":"Altered surface expression of effector cell molecules on neutrophils in myelodysplastic syndromes","volume":"98","author":"A Ohsaka","year":"1997","journal-title":"Br J Haematol"},{"issue":"1","key":"pone.0360063.ref022","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41598-024-52922-7","article-title":"A neutrophil extracellular trap-related risk score predicts prognosis and characterizes the tumor microenvironment in multiple myeloma","volume":"14","author":"Z Zhao","year":"2024","journal-title":"Sci Rep"},{"key":"pone.0360063.ref023","doi-asserted-by":"crossref","first-page":"1365460","DOI":"10.3389\/fonc.2024.1365460","article-title":"Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myeloma","volume":"14","author":"G Gao","year":"2024","journal-title":"Front Oncol"},{"issue":"14","key":"pone.0360063.ref024","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.3390\/ijms21145002","article-title":"Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma","volume":"21","author":"S Akhtar","year":"2020","journal-title":"Int J Mol Sci"},{"key":"pone.0360063.ref025","doi-asserted-by":"crossref","first-page":"155271","DOI":"10.1016\/j.cyto.2020.155271","article-title":"Cytokine profile in multiple myeloma","volume":"136","author":"S Jasrotia","year":"2020","journal-title":"Cytokine"},{"issue":"3","key":"pone.0360063.ref026","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1179\/1607845415Y.0000000029","article-title":"Dysregulation of the NLRP3 inflammasome complex and related cytokines in patients with multiple myeloma","volume":"21","author":"Y Li","year":"2016","journal-title":"Hematology"},{"issue":"5","key":"pone.0360063.ref027","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ejh.13839","article-title":"The evolution of immune dysfunction in multiple myeloma","volume":"109","author":"CY Soekojo","year":"2022","journal-title":"Eur J Haematol"},{"issue":"4","key":"pone.0360063.ref028","doi-asserted-by":"crossref","DOI":"10.1159\/000322830","article-title":"Sample size calculations","volume":"118","author":"M Noordzij","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"pone.0360063.ref029","first-page":"9780471462422","article-title":"Sample size calculation for comparing means","volume":"10","author":"H Wang","year":"2007","journal-title":"Wiley Encycl Clin Trials"},{"key":"pone.0360063.ref030","doi-asserted-by":"crossref","first-page":"100309","DOI":"10.1016\/j.conctc.2018.100309","article-title":"Comparing different ways of calculating sample size for two independent means: A worked example","volume":"13","author":"L Clifton","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"issue":"12","key":"pone.0360063.ref031","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1080\/02664763.2013.819417","article-title":"Efficient sample size allocation with cost constraints for heterogeneous-variance group comparison","volume":"40","author":"J-H Guo","year":"2013","journal-title":"J Appl Stat"},{"issue":"12","key":"pone.0360063.ref032","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"SV Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"15","key":"pone.0360063.ref033","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"PR Greipp","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0360063.ref034","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/ejh.14200","article-title":"Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy","volume":"113","author":"S Askman","year":"2024","journal-title":"Eur J Haematol"},{"issue":"1","key":"pone.0360063.ref035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10238-024-01411-2","article-title":"Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects","volume":"24","author":"V Desantis","year":"2024","journal-title":"Clin Exp Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:25:01Z","timestamp":1791480301000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360063"}},"subtitle":[],"editor":[{"given":"Zivanai Cuthbert","family":"Chapanduka","sequence":"first","affiliation":[{"name":"Stellenbosch University Faculty of Medicine and Health Sciences","place":["SOUTH AFRICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0360063","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}